AIM
AIM ImmunoTech
33 hedge funds and large institutions have $3.15M invested in AIM ImmunoTech in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.52M | |
| 2 | +$38.6K | |
| 3 | +$36.5K | |
| 4 |
VF
Virtu Financial
New York
|
+$21K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$18.4K |
Top Sellers
| 1 | -$11.3K | |
| 2 | -$7.93K | |
| 3 | -$7.45K | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$6.71K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$245 |